帕金森病中的蛋白质机制和治疗设计:结构生物学视角
Danielle M Simons1, Jean-François Trempe2
1Department of Pharmacology & Therapeutics and Centre de Recherche en Biologie Structurale, McGill University, Montreal, Quebec, Canada.
Current opinion in neurobiology
|November 17, 2025
概括
了解帕金森病 (PD) 需要探索像α-synuclein和LRRK2.这样的关键蛋白质. 新的结构洞察力正在指导针对这些蛋白质的新疗法,以改善这种渐进的神经疾病的治疗.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种具有复杂病理学的渐进性神经系统疾病.
- 目前的治疗方法,如多巴胺替代剂,提供症状缓解,但不能治愈.
- 对神经退行机制的更深入的理解对于开发疾病修饰疗法至关重要.
研究的目的:
- 审查了解帕金森病治疗六个关键蛋白质点的最新进展.
- 突出突出新的结构信息,阐明病原机制和治疗策略.
- 讨论目前正在临床试验中的针对这些蛋白质的药物以及结构生物学在优化中所扮演的角色.
主要方法:
- 最近科学出版物的文献综述.
- 对PD相关蛋白质的新型结构数据的分析.
- 对针对特定蛋白质的PD治疗药物的正在进行的临床试验的审查.
主要成果:
- 最近的结构研究为α-synuclein,LRRK2,GBA1,PARKIN,PINK1和USP30的功能和功能障碍提供了新的见解.
- 这些结构发现正在为新型治疗剂的开发提供信息.
- 针对这些蛋白质的几种药物正在进行临床试验,结构数据有助于药物设计.
结论:
- 结构生物学方面的进步对于破译PD病变的产生至关重要.
- 针对像α-synuclein,LRRK2和GBA1这样的特定蛋白质,有望成为有效的PD治疗方法.
- 结构性见解正在加速对帕金森病进行改进的疾病修饰疗法的开发.
更多相关视频
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Protein Kinases and Phosphatases
14.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.9K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K


